Form 4: Health Catalyst Director Acquires 8,361 Shares via RSU Vesting

Health Catalyst Director Julie Larson-Green acquired 8,361 shares of common stock through RSU vesting on March 1, 2026.

Summary

• Julie Larson-Green, a Director of Health Catalyst, Inc. (HCAT), acquired 8,361 shares of common stock.
• The acquisition occurred on March 1, 2026, at a transaction price of $0.00 per share.
• This transaction represents the vesting of Restricted Stock Units (RSUs) granted under the Issuer's 2019 Stock Option and Incentive Plan.
• 100% of these RSUs vested on March 1, 2026, in accordance with the Issuer's Non-Employee Director Compensation Policy.
• Following this transaction, Julie Larson-Green beneficially owns a total of 81,934 shares of Health Catalyst common stock.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive event. While RSU vesting is a scheduled compensation event, the increase in a director's beneficial ownership aligns their interests with shareholders, which is generally favorable.

Positives

• The vesting of Restricted Stock Units (RSUs) for a director indicates continued alignment of management interests with shareholder value.
• The increase in beneficial ownership by a director can be viewed as a positive signal of confidence in the company's future.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

StockSavvy.ai notes that insider transactions, such as RSU vestings, are routine compensation events for directors and executives in the healthcare technology sector. While not indicative of broader industry trends, they reflect standard corporate governance practices for aligning leadership incentives with company performance.

Related Party Transactions

• Acquisition of 8,361 common stock shares by Director Julie Larson-Green through the vesting of Restricted Stock Units (RSUs) under the Issuer's 2019 Stock Option and Incentive Plan and Non-Employee Director Compensation Policy.

Stakeholder Impact

• Shareholders: The increase in director ownership aligns management's interests with shareholder value, potentially fostering long-term growth and stability.

Key Dates

Recommendation

This Form 4 reports a routine RSU vesting for a director, which is a pre-scheduled compensation event and does not typically signal a significant change in the company's fundamental outlook or warrant a strong buy or sell recommendation. It primarily reflects ongoing compensation practices and director alignment.

Keywords

Health Catalyst, HCAT, Insider Transaction, Form 4, Restricted Stock Units, RSU, Director, Stock Acquisition, Corporate Governance